GLOBAVIR
Globavir was founded in 2011 by Dr. Shalabh Gupta. Globavir was built on multiple licenses from Stanford University from multiple different professors and multiple different departments. In 2014, Globavir acquired BioCycive in all stock deal, and BioCycive became a wholly owned subsidiary of Globavir. In 2015, BioCycive's lead program was partnered with Sorrento Therapeutics. In 2016, Globavir partnered its diagnostic test with Bio-Rad.
GLOBAVIR
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2013-07-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.globavir.com
Total Employee:
11+
Status:
Active
Contact:
+116503514495
Email Addresses:
[email protected]
Total Funding:
11.5 M USD
Technology used in webpage:
SPF LetsEncrypt Apache Euro Google Apps For Business Unified Layer BlueHost BlueHost DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
StartX (Stanford-StartX Fund)
StartX (Stanford-StartX Fund) investment in Venture Round - Globavir
Sorrento Therapeutics
Sorrento Therapeutics investment in Venture Round - Globavir
Official Site Inspections
http://www.globavir.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.56 K
Unable to get host informations!!!
More informations about "Globavir"
Globavir Biosciences Company Profile 2024: Valuation, …
Globavir Biosciences General Information Description. Developer of therapeutics and diagnostics designed for the treatment of global infectious diseases. The company creates and researches therapeutics to address certain infectious …See details»
Globavir - VentureRadar
Globavir's development strategy harnesses the advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies. Globavir is initially focused on the …See details»
Globavir Biosciences - Products, Competitors, Financials, …
Globavir is a specialty biotechnology company with a unique approach to unlocking the potential of the 505(b)(2) regulatory path. Globavir leverages its highly predictive, machine learning …See details»
Globavir Biosciences, Inc. Company Profile | Los Altos, CA ...
Find company research, competitor information, contact details & financial data for Globavir Biosciences, Inc. of Los Altos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Globavir Biosciences Inc - Company Profile and News
Globavir Biosciences, Inc. is an infectious disease-focused company. Globavir researches and develops therapeutics to address certain infectious diseases such as Dengue, West Nile, …See details»
Globavir Biosciences, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Globavir Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:GBV-006, GBV-042, GBV-033, GBV-3019, GBV-2034. ... The statistics for drugs …See details»
Globavir - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Globavir Biosciences - Craft
Globavir Biosciences is a biotechnology company that develops therapeutics for infectious diseases and oncology, and diagnostics for infectious diseases. Globavir's platform discovery …See details»
Globavir Biosciences - Company info. interviews, news
Aug 18, 2022 Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious …See details»
Globavir - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Globavir . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board …See details»
Globavir, Inc. - Los Altos, USA - bionity.com
Globavir strives to develop medicines that will revolutionize the treatment of infectious diseases Globavir's Infectious Disease pipeline includes GBV006, a broad spectrum antiviral being …See details»
Globavir Announces Licensing Agreement with Bio-Rad for …
Oct 17, 2016 Globavir is excited to lend our dengue technology toward the creation of this important assay." ... According to the World Health Organization, the global incidence of …See details»
Globavir Biosciences, Inc. Announces Licensing Agreement
Oct 17, 2016 Globavir is excited to lend our dengue technology toward the creation of this important assay." ... According to the World Health Organization, the global incidence of …See details»
Globavir Announces Partnership With SingHealth Duke-NUS
Dec 18, 2017 Globavir Biosciences announced a partnership with the SingHealth Duke-NUS Academic Medical Centre in Singapore, through its newly established ViREMiCS, to conduct …See details»
Globavir Biosciences, Inc. Company Profile | Los Altos, CA ...
Globavir Biosciences, Inc. Company Profile | Los Altos, CA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Research programme: oncology therapeutics - Globavir
Sep 1, 2016 Globavir is using its data-driven, computational Globavir drug discovery platform to develop a pipeline of small molecule oncology therapeutics. These early Research …See details»
International Pathogen Surveillance Network announces first …
4 days ago The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to improve capacities in pathogen genomic surveillance. …See details»
Globavir - Clinical Trials, Evidence, Medical - HealthTech Alpha
Globavir is focused on commercializing re-purposed drugs for controlling diseases with large unmet medical needs such as Coronavirus, Dengue Fever, Ebola, and Chikungunya. …See details»
Globavir - Updates, News, Events, Signals & Triggers - Crunchbase
A New Approach to Treating Global Infectious DiseasesSee details»
Manager, Global Organization Design - McDonald's Restaurant …
McDonald’s Organization Effectiveness Team is dedicated to optimizing the way the organization operates in today’s fast-paced, rapidly changing business environment. As leadership shares …See details»